Adoptive T cell transfer, in which PD-1 was genetically disrupted, was performed in 12 patients suffering from metastatic non-small cell lung cancer (NSCLC) and 17 patients with advanced esophageal squamous cell carcinoma (ESCC). Here, PDCD1 is linked to non-small cell lung carcinoma.